Michael Cukan

Statistics

Publications

Citations

921

H-Index

Active since

2006

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Michael Cukan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in monoclonal antibodies, pharmacy, and protein engineering.

ORCID

Publications per year

2006–2012

Publications

Optimization of humanized IgGs in glycoengineered Pichia pastoris

Huijuan Li, Natarajan Sethuraman, Terrance A. Stadheim et al. · Nature Biotechnology · 2006 · 427 citations

Engineering, Bioengineering, Biotechnology +12

Production of monoclonal antibodies by glycoengineered Pichia pastoris

Thomas I. Potgieter, Michael Cukan, J. E. Drummond et al. · Journal of Biotechnology · 2008 · 162 citations

Pharmacy, Biochemistry, Biotechnology +14

IgG2m4, an engineered antibody isotype with reduced Fc function

Zhiqiang An, Gail Forrest, Renée Moore et al. · mAbs · 2009 · 98 citations · Full text

Pharmacy, Biotechnology, Immunology +17

Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study

Ningyan Zhang, Calin Dan Dumitru, Nga Rewa Houston Cummings et al. · mAbs · 2011 · 94 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response

Byung‐Kwon Choi, Jeffrey K. Actor, Sandra Rios et al. · Glycoconjugate Journal · 2008 · 73 citations · Full text

Life Sciences, Immunology, Microbiology +6

1–5 of 8